4//SEC Filing
Dusseux Eric Michel 4
Accession 0001144204-17-048230
CIK 0001508381other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 2:56 PM ET
Size
6.5 KB
Accession
0001144204-17-048230
Insider Transaction Report
Form 4
Dusseux Eric Michel
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-09-01+6,107,677→ 6,107,677 totalExercise: $0.16Exp: 2027-09-01→ Common Stock, par value $0.001 (6,107,677 underlying)
Footnotes (2)
- [F1]One-sixth of the option will be vested and exercisable as of the September 1, 2017 date of grant, and the unvested portion of the option will become vested and exercisable as follows: (a) 50% in 5 equal annual installments on each of the five anniversaries of the date of the issuance of the option; and (b) 50% in 5 equal separate tranches annually based on Dr. Dusseux's achievement of annual performance goals to be established by the Board in consultation with Dr. Dusseux.
- [F2]The extent to which each separate tranche becomes vested shall be determined by reference to Dr. Dusseux's annual performance as measured by reference to the performance targets set for that performance period. In the event a specific tranche is not fully vested, that tranche shall not be forfeited, but shall remain outstanding, and may become vested as a result of Dr. Dusseux's future performance at an above target level or as a result of accelerated vesting on the occurrence of any other event that triggers accelerated vesting.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001713593
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 2:56 PM ET
- Size
- 6.5 KB